Evidence map›Paper›PMID 25393019›Full record

ArticlePLoS pathogens2014

PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.

Martin Eifler, Ralf Uecker, Henry Weisbach, Boris Bogdanow, Ellen Richter, Lydia König, Barbara Vetter, Tihana Lenac-Rovis, Stipan Jonjic, Heidemarie Neitzel and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. GJournal of virology · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Single-Cell Transcriptome Analysis of CD34Frontiers in microbiology · 2019
    Article
  16. Article
  17. Article
  18. Human cytomegalovirus riding the cell cycle.Medical microbiology and immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Martin EiflerLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ralf UeckerLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Henry WeisbachLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Boris BogdanowLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ellen RichterLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Lydia KönigLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Barbara VetterLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Tihana Lenac-RovisCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Stipan JonjicCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Heidemarie NeitzelInstitut für Medizinische Genetik und Humangenetik, Charité Universitätsmedizin Berlin, Berlin, Germany.
Christian HagemeierLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Lüder WiebuschLabor für Pädiatrische Molekularbiologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEUniversity of Rijeka · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Entry into mitosis is accompanied by dramatic changes in cellular architecture, metabolism and gene expression. Many viruses have evolved cell cycle arrest strategies to prevent mitotic entry, presumably to ensure sustained, uninterrupted viral replication. Here we show for human cytomegalovirus (HCMV) what happens if the viral cell cycle arrest mechanism is disabled and cells engaged in viral replication enter into unscheduled mitosis. We made use of an HCMV mutant that, due to a defective Cyclin A2 binding motif in its UL21a gene product (pUL21a), has lost its ability to down-regulate Cyclin A2 and, therefore, to arrest cells at the G1/S transition. Cyclin A2 up-regulation in infected cells not only triggered the onset of cellular DNA synthesis, but also promoted the accumulation and nuclear translocation of Cyclin B1-CDK1, premature chromatin condensation and mitotic entry. The infected cells were able to enter metaphase as shown by nuclear lamina disassembly and, often irregular, metaphase spindle formation. However, anaphase onset was blocked by the still intact anaphase promoting complex/cyclosome (APC/C) inhibitory function of pUL21a. Remarkably, the essential viral IE2, but not the related chromosome-associated IE1 protein, disappeared upon mitotic entry, suggesting an inherent instability of IE2 under mitotic conditions. Viral DNA synthesis was impaired in mitosis, as demonstrated by the abnormal morphology and strongly reduced BrdU incorporation rates of viral replication compartments. The prolonged metaphase arrest in infected cells coincided with precocious sister chromatid separation and progressive fragmentation of the chromosomal material. We conclude that the Cyclin A2-binding function of pUL21a contributes to the maintenance of a cell cycle state conducive for the completion of the HCMV replication cycle. Unscheduled mitotic entry during the course of the HCMV replication has fatal consequences, leading to abortive infection and cell death.

Indexed as

DNA ReplicationVirus ReplicationCell CycleCell Cycle CheckpointsCell LineCyclin A2CytomegalovirusGene Expression RegulationHumansImmediate-Early ProteinsMitosisProteasome Endopeptidase ComplexProtein Interaction MappingTrans-ActivatorsUp-RegulationViral ProteinsCCNA2 protein, humanCyclin A2IE2 protein, CytomegalovirusImmediate-Early ProteinsProteasome Endopeptidase ComplexTrans-ActivatorsViral Proteins

Identifiers

PMID25393019
PMCPMC4231158
OpenAlexW2136736950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.